Search results
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
Investor's Business Daily· 1 year agoAmgen will buy Horizon Therapeutics for $28.3 billion in the biggest biopharma deal of the year. In...
Stocks jump as Fed looks to moderate pace of interest rate hikes; NIO and HZNP in focus
TipRanks via Yahoo Finance· 1 year agoWell, it’s official. Federal Reserve chair Jerome Powell has signaled that the central bank is...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
If You Invested $1000 in Horizon Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 1 year agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Why Amgen Stock Slumped on Monday
Motley Fool· 10 months agoAmgen (NASDAQ: AMGN) stock came under renewed pressure on Monday, several days after more regulators piled on to block a major acquisition announced by...
Hedge Funds Continue to Load Up on These 10 Growth Stocks Despite Recession Fears
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 10 growth stocks that hedge funds continue to load up on despite...
Stock Market Closes Higher Ahead Of Fed Meeting On Expected Lower Inflation; Energy, Tech Stocks...
Investor's Business Daily· 1 year agoThe stock market closed higher on expectations that inflation rates will drop ahead of news from the...
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Benzinga via Yahoo Finance· 1 year agoCanaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ: SELB) from $9...
Dow Jones Holds Gains; Fed, CPI On Deck; IBD 50 Leads With Breakout Among Its Stocks
Investor's Business Daily· 1 year agoThe Dow Jones Industrial Average remained higher at midday, ahead of the last Fed meeting of 2022....
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
Investor's Business Daily· 1 year agoThe stock market rally came under pressure, with the Nasdaq breaking below its 50-day line and the...
